The paper “Predictors of Clinical Metastases and Survival among Non-Metastatic Prostate Cancer Patients Treated with Androgen-Deprivation Therapy in Sweden”, co-authored by Jonas Banefelt and Johan Mesterton, was presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.